Rhinorelief 200 mg/30 mg tablete
| Name | Rhinorelief 200 mg/30 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-550772325 |
| Active Substance | ibuprofen pseudoefedrinklorid |
| Composition | 1 tableta sadrži 200 mg ibuprofena i 30 mg pseudoefedrinklorida |
| Pharmaceutical Form | tableta |
| Packaging [MA Number for Packaging] | 20 tableta u blisteru, u kutiji [HR-H-550772325-01] |
| Manufacturer | Jadran Galenski laboratorij d.d., Rijeka, Republika Hrvatska |
| Marketing Authorisation Holder | Jadran Galenski laboratorij d.d., Svilno 20, Rijeka |
| Marketing Authorisation Date | 21.02.2019 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/577 |
| Registration Number | 381-12-01/30-19-07 |
| Prescription | bez recepta |
| Distribution | u ljekarni |
| Advertising to general public | dopušteno |
| ATC Code | M01AE01 |
| Medicinal product marketed in the Croatia | Nestašica |
| SmPC | download |
| PL | download |
Direct Healthcare Professional Communication
| Name | Date | Download |
|---|---|---|
| Pismo zdravstvenim radnicima o riziku od sindroma posteriorne reverzibilne encefalopatije i sindroma reverzibilne cerebralne vazokonstrikcije uz primjenu lijekova koji sadrže pseudoefedrin | 09.02.2024 | Alkaloid d.o.o., Bayer d.o.o., Pliva Hrvatska d.o.o., Reckitt Benckiser d.o.o., Krka - farma d.o.o., Bosnalijek d.o.o., Jadran Galenski laboratorij d.d. |
